Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results
- 1 August 1997
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 24 (6) , 485-498
- https://doi.org/10.1016/s0969-8051(97)00066-8
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Imaging of dopamine transporters in humans with technetium-99m TRODAT 1European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Technetium(v) and rhenium(v) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerationsNuclear Medicine and Biology, 1996
- Modulation of nmda and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disordersLife Sciences, 1996
- Synthesis, characterization and biodistribution of neutral and lipid-soluble 99mTc-bisaminoethanethiol spiperone derivatives: Possible ligands for receptor imaging with SPECTNuclear Medicine and Biology, 1995
- Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systemsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Subtypes of receptors for neuropeptide Y: Implications for the targeting of therapeuticsLife Sciences, 1994
- Technetium-99m labeled somatostatin and analogs: Synthesis, characterization and in vivo evaluationNuclear Medicine and Biology, 1993
- Synthesis and in vivo evaluation of [18F]-N-(p-Nitrobenzyl)spiperone ([18F]PNBS) in ratsNuclear Medicine and Biology, 1993
- Radiopharmaceuticals: state of the artEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981